Position in EVO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$37,972
-$1,830 QoQ
Shares Held
15,189
+17.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
4 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in EVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $609,159,561 across 30 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
4,217,767 | $146,229,981 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
4,432,350 | $109,080,132 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
773,978 | $85,865,119 | |
| 4 | ALKS |
Alkermes plc.
|
969,954 | $50,825,589 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
270,754 | $45,632,878 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
2,025,356 | $29,347,408 | |
| 7 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
1,066,322 | $21,518,377 | |
| 8 | ZTS |
Zoetis Inc.
|
257,470 | $18,501,794 |
All Filings in EVO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $37,972 | 15,189 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $39,802 | 12,923 | Shares | Other | 2026-02-13 | |
| 2025-06-30 | $169,302 | 40,310 | Shares | Other | 2025-08-13 | |
| 2021-12-31 | $386,460 | 16,272 | Shares | Other | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||